Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44
Year: 2020
Type: article
Source: Nature Cancer
Authors: Amy L. Cummings, Jaklin Gukasyan, Henry Y. Lu, Tristan Grogan, Gemalene Sunga, Charlene M. Fares, Nicholas Hornstein, Jesse Zaretsky, James Carroll, Benjamin Bachrach, Wisdom O. Akingbemi, Debory Li, Zorawar Noor, Aaron Lisberg, Jonathan W. Goldman, David Elashoff, Alex A. T. Bui, Antoni Ribas, Steven M. Dubinett, Maura Rossetti, Edward B. Garon
Institution: University of California, Los Angeles
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer, G183821942, G2399781033, G3062386909, G343705321, Individually-tailored clinical decision support for management of indeterminate pulmonary nodules, G562087445, Intratumoral Administration of CCL21-gene Modified Dendritic Cell With Intravenous Pembrolizumab for Advanced NSCLC, UCLA Tumor Immunology Institutional Training Grant, Cancer Center Support Grant
OpenAlex ID: W3104635171
